Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb;40(2):355-366.
doi: 10.1111/jgh.16873. Epub 2025 Jan 8.

Glucose Metabolism Reprogramming of Immune Cells in the Microenvironment of Pancreatic and Hepatobiliary Cancers

Yongqing Zhao  1 , Weixiong Zhu  1 , Shi Dong  1 , Hui Zhang  1   2 , Wence Zhou  1   2   3
Affiliations
Review

Glucose Metabolism Reprogramming of Immune Cells in the Microenvironment of Pancreatic and Hepatobiliary Cancers

Yongqing Zhao et al. J Gastroenterol Hepatol. 2025 Feb.

Abstract

Background and aim: Pancreatic and hepatobiliary cancers are increasing in prevalence and contribute significantly to cancer-related mortality worldwide. Emerging therapeutic approaches, particularly immunotherapy, are gaining attention for their potential to harness the patient's immune system to combat these tumors. Understanding the role of immune cells in the tumor microenvironment (TME) and their metabolic reprogramming is key to developing more effective treatment strategies. This review aims to explore the relationship between immune cell function and glucose metabolism in the TME of pancreatic and hepatobiliary cancers.

Methods: This review synthesizes current research on the metabolic adaptations of immune cells, specifically focusing on glucose metabolism within the TME of pancreatic and hepatobiliary cancers. We examine the mechanisms by which immune cells influence tumor progression through metabolic reprogramming and how these interactions can be targeted for therapeutic purposes.

Results: Immune cells in the TME undergo significant metabolic changes, with glucose metabolism playing a central role in modulating immune responses. These metabolic shifts not only affect immune cell function but also influence tumor behavior and progression. The unique metabolic features of immune cells in pancreatic and hepatobiliary cancers provide new opportunities for targeting immune responses to combat these malignancies more effectively.

Conclusion: Understanding the complex relationship between immune cell glucose metabolism and tumor progression in the TME of pancreatic and hepatobiliary cancers offers promising therapeutic strategies. By modulating immune responses through targeted metabolic interventions, it may be possible to improve the efficacy of immunotherapies and better combat these aggressive cancers.

Keywords: glucose metabolism; immune cell; immunotherapy; tumor microenvironment.

PubMed Disclaimer

References

    1. F. Bray, M. Laversanne, H. Sung, et al., “Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 74, no. 3 (2024): 229–263.
    1. A. P. Klein, “Pancreatic Cancer Epidemiology: Understanding the Role of Lifestyle and Inherited Risk Factors,” Nature Reviews. Gastroenterology & Hepatology 18, no. 7 (2021): 493–502.
    1. K. E. de Visser and J. A. Joyce, “The Evolving Tumor Microenvironment: From Cancer Initiation to Metastatic Outgrowth,” Cancer Cell 41, no. 3 (2023): 374–403.
    1. K. Sobierajska, W. M. Ciszewski, I. Sacewicz‐Hofman, and J. Niewiarowska, “Endothelial Cells in the Tumor Microenvironment,” Advances in Experimental Medicine and Biology 1234 (2020): 71–86.
    1. G. Biffi and D. A. Tuveson, “Diversity and Biology of Cancer‐Associated Fibroblasts,” Physiological Reviews 101, no. 1 (2021): 147–176.

MeSH terms

LinkOut - more resources